Trafalgar International (GCAN) EBIT (QoQ) (2017 - 2026)
Trafalgar International (GCAN) EBIT (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.97% |
| Dec 31, 2025 | -43.82% |
| Sep 30, 2025 | 22.46% |
| Jun 30, 2025 | -10.83% |
| Mar 31, 2025 | -15.71% |
| Dec 31, 2024 | 6.97% |
| Sep 30, 2024 | -3.02% |
| Jun 30, 2024 | -0.79% |
| Mar 31, 2024 | 11.53% |
| Dec 31, 2023 | 12.76% |
| Sep 30, 2023 | -21.88% |
| Jun 30, 2023 | -4.91% |
| Mar 31, 2023 | 6.62% |
| Dec 31, 2022 | 14.27% |
| Sep 30, 2022 | -14.57% |
| Jun 30, 2022 | -1.42% |
| Mar 31, 2022 | 64.67% |
| Dec 31, 2021 | -61.56% |
| Sep 30, 2021 | -18.99% |
| Jun 30, 2021 | 27.55% |